NLRP3 and Parkinson disease: Taken together, these results indicate that DA could serve as an endogenous inhibitor for the NLRP3 inflammasome activation that is associated with multiple facets of PD, including α-syn pathology, neuroinflammation, and dopaminergic neurodegeneration.